Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859754 · ClinicalTrials.gov registry record
Octagam 5% Versus Comparator Post Marketing Trial
A clinical trial, sponsored by Octapharma.
- Completed
- Registry status
- 623
- Enrollment target
NCT01859754 is a clinical trial that has completed, run by Octapharma. The registered enrollment target is 623 participants.
The verdict
NCT01859754 has completed, sponsored by Octapharma.
- COMPLETED
- Registry status
- 623 participants
- Enrollment target
Study Summary
Study Design: This is a 2 arm non-interventional trial that will compare the occurrence of adverse drug reactions between Octagam 5% and other marketed IVIG infusion treatments.
Interventions
- BIOLOGICAL Octagam 5%
- BIOLOGICAL Other marketed IVIG product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 623 participants |
| Start Date | 2013-05-21 |
| Est. Completion | 2019-05-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01859754
The ClinicalTrials.gov registry entry for NCT01859754 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 623 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Octapharma, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Octagam 5% is the first listed.
NCT01859754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01859754 about?
NCT01859754 is a clinical study titled "Octagam 5% Versus Comparator Post Marketing Trial". Study Design: This is a 2 arm non-interventional trial that will compare the occurrence of adverse drug reactions between Octagam 5% and other marketed IVIG infusion treatments.
What is the current status of trial NCT01859754?
This trial is currently completed. The enrollment target is 623 participants. The study started on 2013-05-21. Estimated completion is 2019-05-22.
What interventions are being tested in trial NCT01859754?
The interventions under investigation include: Octagam 5% (BIOLOGICAL), Other marketed IVIG product (BIOLOGICAL).
Who is sponsoring clinical trial NCT01859754?
This trial is sponsored by Octapharma, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.